CUSIP: 885260109
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,029,976
-
Share change
-
+2,919,320
-
Total reported value
-
$81,824,956
-
Put/Call ratio
-
146%
-
Price per share
-
$10.19
-
Number of holders
-
57
-
Value change
-
+$41,720,457
-
Number of buys
-
41
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 885260109?
CUSIP 885260109 identifies THRN - THORNE HEALTHTECH INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP 885260109:
Institutional Holders of THORNE HEALTHTECH INC - COM (THRN) as of Q3 2023
As of 30 Sep 2023,
THORNE HEALTHTECH INC - COM (THRN) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,029,976 shares.
The largest 10 holders included
GLAZER CAPITAL, LLC, VANGUARD GROUP INC, GABELLI FUNDS LLC, BlackRock Inc., Beryl Capital Management LLC, ALPINE ASSOCIATES MANAGEMENT INC., Qube Research & Technologies Ltd, GEODE CAPITAL MANAGEMENT, LLC, Cresset Asset Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.